• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Reduced olfactory bulb volume accompanies olfactory dysfunction after mild SARS-CoV-2 infection

tetano

Editor, Senior Moderator
Sci Rep


. 2024 Jun 11;14(1):13396.
doi: 10.1038/s41598-024-64367-z. Reduced olfactory bulb volume accompanies olfactory dysfunction after mild SARS-CoV-2 infection

Marvin Petersen[SUP] #[/SUP][SUP] 1 [/SUP], Benjamin Becker[SUP] #[/SUP][SUP] 2 [/SUP], Maximilian Schell[SUP] 3 [/SUP], Carola Mayer[SUP] 3 [/SUP], Felix L Naegele[SUP] 3 [/SUP], Elina Petersen[SUP] 4 5 [/SUP], Raphael Twerenbold[SUP] 4 5 6 7 [/SUP], Götz Thomalla[SUP] 3 [/SUP], Bastian Cheng[SUP] 3 [/SUP], Christian Betz[SUP] 2 [/SUP], Anna S Hoffmann[SUP] 2 [/SUP]



Affiliations
Abstract

Despite its high prevalence, the determinants of smelling impairment in COVID-19 remain not fully understood. In this work, we aimed to examine the association between olfactory bulb volume and the clinical trajectory of COVID-19-related smelling impairment in a large-scale magnetic resonance imaging (MRI) analysis. Data of non-vaccinated COVID-19 convalescents recruited within the framework of the prospective Hamburg City Health Study COVID Program between March and December 2020 were analyzed. At baseline, 233 participants underwent MRI and neuropsychological testing as well as a structured questionnaire for olfactory function. Between March and April 2022, olfactory function was assessed at follow-up including quantitative olfactometric testing with Sniffin' Sticks. This study included 233 individuals recovered from mainly mild to moderate SARS-CoV-2 infections. Longitudinal assessment demonstrated a declining prevalence of self-reported olfactory dysfunction from 67.1% at acute infection, 21.0% at baseline examination and 17.5% at follow-up. Participants with post-acute self-reported olfactory dysfunction had a significantly lower olfactory bulb volume at baseline than normally smelling individuals. Olfactory bulb volume at baseline predicted olfactometric scores at follow-up. Performance in neuropsychological testing was not significantly associated with the olfactory bulb volume. Our work demonstrates an association of long-term self-reported smelling dysfunction and olfactory bulb integrity in a sample of individuals recovered from mainly mild to moderate COVID-19. Collectively, our results highlight olfactory bulb volume as a surrogate marker that may inform diagnosis and guide rehabilitation strategies in COVID-19.


 
Back
Top Bottom